Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan Miller

Showing results (201-210 of 224) with videos related to

Pageof 23
Sort By:
Brain Pathology (Zurich, Switzerland)|May 6, 2025
Comparative pathology boards facilitate the translation of knowledge between canine and human cancer patientsJessica A Beck, Christina Mazcko, Sara Belluco, et al.
Neuro-Oncology Advances|September 14, 2023
Combined inhibition of topoisomerase I and poly(ADP-ribose) polymerase: A synergistic therapeutic strategy for glioblastoma with phosphatase and tensin homolog deficiencyOlga Kim, Madison Butler, Zach Sergi, et al.
Brain Pathology (Zurich, Switzerland)|March 5, 2013
Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous systemAditya Raghunathan, Khalida Wani, Terri S Armstrong, et al.
Neuro-Oncology|May 15, 2016
Creation of an NCI comparative brain tumor consortium: informing the translation of new knowledge from canine to human brain tumor patientsAmy K LeBlanc, Christina Mazcko, Diane E Brown, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 30, 2015
Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER ConsortiumEmma H Allott, Stephanie M Cohen, Joseph Geradts, et al.
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
Real-world analysis of strategies to prevent thrombosis and bleeding in adults with ALL treated with asparaginaseJoseph F Mort, David Brighton, Benjamin Mautner, et al.
Neurobiology of Disease|June 9, 2026
Human TDP-43 expression worsens FTD-related phenotypes in progranulin-insufficient miceAnna K Cook, Benjamin Lin, Yumo Song, et al.
Breast Cancer Research and Treatment|June 26, 2018
LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastasesAmanda E D Van Swearingen, Marni B Siegel, Allison M Deal, et al.
The Journal of Clinical Investigation|April 16, 2013
MERTK receptor tyrosine kinase is a therapeutic target in melanomaJennifer Schlegel, Maria J Sambade, Susan Sather, et al.
Neuro-Oncology|April 6, 2017
Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastomaRobert S McNeill, Demitra A Canoutas, Timothy J Stuhlmiller, et al.
Pageof 23

Showing results (201-210 of 224) with videos related to

Sort By:
Pageof 23
Brain Pathology (Zurich, Switzerland)|May 6, 2025
Comparative pathology boards facilitate the translation of knowledge between canine and human cancer patientsJessica A Beck, Christina Mazcko, Sara Belluco, et al.
Neuro-Oncology Advances|September 14, 2023
Combined inhibition of topoisomerase I and poly(ADP-ribose) polymerase: A synergistic therapeutic strategy for glioblastoma with phosphatase and tensin homolog deficiencyOlga Kim, Madison Butler, Zach Sergi, et al.
Brain Pathology (Zurich, Switzerland)|March 5, 2013
Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous systemAditya Raghunathan, Khalida Wani, Terri S Armstrong, et al.
Neuro-Oncology|May 15, 2016
Creation of an NCI comparative brain tumor consortium: informing the translation of new knowledge from canine to human brain tumor patientsAmy K LeBlanc, Christina Mazcko, Diane E Brown, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 30, 2015
Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER ConsortiumEmma H Allott, Stephanie M Cohen, Joseph Geradts, et al.
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
Real-world analysis of strategies to prevent thrombosis and bleeding in adults with ALL treated with asparaginaseJoseph F Mort, David Brighton, Benjamin Mautner, et al.
Neurobiology of Disease|June 9, 2026
Human TDP-43 expression worsens FTD-related phenotypes in progranulin-insufficient miceAnna K Cook, Benjamin Lin, Yumo Song, et al.
Breast Cancer Research and Treatment|June 26, 2018
LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastasesAmanda E D Van Swearingen, Marni B Siegel, Allison M Deal, et al.
The Journal of Clinical Investigation|April 16, 2013
MERTK receptor tyrosine kinase is a therapeutic target in melanomaJennifer Schlegel, Maria J Sambade, Susan Sather, et al.
Neuro-Oncology|April 6, 2017
Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastomaRobert S McNeill, Demitra A Canoutas, Timothy J Stuhlmiller, et al.
Pageof 23